BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8630399)

  • 1. Inhibition of CD4 cross-linking-induced lymphocytes apoptosis by vesnarinone as a novel immunomodulating agent: vesnarinone inhibits Fas expression and apoptosis by blocking cytokine secretion.
    Oyaizu N; McCloskey TW; Than S; Pahwa S
    Blood; 1996 Mar; 87(6):2361-8. PubMed ID: 8630399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion.
    Oyaizu N; McCloskey TW; Than S; Hu R; Kalyanaraman VS; Pahwa S
    Blood; 1994 Oct; 84(8):2622-31. PubMed ID: 7522637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of apoptosis in peripheral blood mononuclear cells of HIV-infected patients.
    Oyaizu N; McCloskey TW; Than S; Hu R; Pahwa S
    Adv Exp Med Biol; 1995; 374():101-14. PubMed ID: 7572384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway.
    Tateyama M; Oyaizu N; McCloskey TW; Than S; Pahwa S
    Blood; 2000 Jul; 96(1):195-202. PubMed ID: 10891451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: a possible mechanism of bystander cell death in HIV infection.
    Oyaizu N; Adachi Y; Hashimoto F; McCloskey TW; Hosaka N; Kayagaki N; Yagita H; Pahwa S
    J Immunol; 1997 Mar; 158(5):2456-63. PubMed ID: 9036997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Bcl-2 protein by CD4 cross-linking: a possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2.
    Hashimoto F; Oyaizu N; Kalyanaraman VS; Pahwa S
    Blood; 1997 Jul; 90(2):745-53. PubMed ID: 9226175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates apoptotic death.
    Tsushima H; Imaizumi Y; Imanishi D; Fuchigami K; Tomonaga M
    Exp Hematol; 1999 Mar; 27(3):433-40. PubMed ID: 10089905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons.
    Estaquier J; Idziorek T; Zou W; Emilie D; Farber CM; Bourez JM; Ameisen JC
    J Exp Med; 1995 Dec; 182(6):1759-67. PubMed ID: 7500020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesnarinone inhibits immune-mediated but not Fas (CD95) agonist-mediated hepatic injury.
    Lazarus DD; Kambayashi T; Yato-Kioka M; Baumann H; Jacob CO; Strassmann G
    Int J Immunopharmacol; 1997 Jan; 19(1):49-58. PubMed ID: 9226479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 cross-linking (CD4XL) induces RAS activation and tumor necrosis factor-alpha secretion in CD4+ T cells.
    Tamma SM; Chirmule N; Yagura H; Oyaizu N; Kalyanaraman V; Pahwa S
    Blood; 1997 Aug; 90(4):1588-93. PubMed ID: 9269777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of vesnarinone on TNF alpha production in human peripheral blood mononuclear cells and microglia: a preclinical study for the treatment of multiple sclerosis.
    Jiang H; Bielekova B; Okazaki H; Clarence-Smith K; Johnson KP; Bergey G; Martin R; Dhib-Jalbut S
    J Neuroimmunol; 1999 Jun; 97(1-2):134-45. PubMed ID: 10408967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inotropic agent vesnarinone inhibits cytokine production and E-selectin expression in human umbilical vein endothelial cells.
    Sato Y; Matsumori A; Sasayama S
    J Mol Cell Cardiol; 1995 Oct; 27(10):2265-73. PubMed ID: 8576941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals.
    Katsikis PD; Wunderlich ES; Smith CA; Herzenberg LA; Herzenberg LA
    J Exp Med; 1995 Jun; 181(6):2029-36. PubMed ID: 7539037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells.
    Mueller YM; Makar V; Bojczuk PM; Witek J; Katsikis PD
    Int Immunol; 2003 Jan; 15(1):49-58. PubMed ID: 12502725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure.
    Matsumori A; Shioi T; Yamada T; Matsui S; Sasayama S
    Circulation; 1994 Mar; 89(3):955-8. PubMed ID: 8124835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha mediated apoptosis of CD4 positive T-lymphocytes. A model of T-cell depletion in HIV infected individuals.
    Klein SA; Dobmeyer JM; Dobmeyer TS; Falke D; Kabelitz D; Friese K; Helm EB; Hoelzer D; Rossol-Voth R
    Eur J Med Res; 1996 Feb; 1(5):249-58. PubMed ID: 9374446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2.
    Egle A; Villunger A; Kos M; Böck G; Gruber J; Auer B; Greil R
    Eur J Immunol; 1996 Dec; 26(12):3119-26. PubMed ID: 8977313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists.
    Estaquier J; Tanaka M; Suda T; Nagata S; Golstein P; Ameisen JC
    Blood; 1996 Jun; 87(12):4959-66. PubMed ID: 8652808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement of CD4 before TCR triggering regulates both Bax- and Fas (CD95)-mediated apoptosis.
    Somma F; Tuosto L; Gilardini Montani MS; Di Somma MM; Cundari E; Piccolella E
    J Immunol; 2000 May; 164(10):5078-87. PubMed ID: 10799864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesnarinone is a selective inhibitor of macrophage TNF(alpha) release.
    Kambayashi T; Mazurek N; Jacob CO; Wei N; Fong M; Strassmann G
    Int J Immunopharmacol; 1996; 18(6-7):371-8. PubMed ID: 9024938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.